首页 | 本学科首页   官方微博 | 高级检索  
   检索      


The discovery of non-basic atrial natriuretic peptide clearance receptor antagonists. Part 1
Authors:Veale C A  Alford V C  Aharony D  Banville D L  Bialecki R A  Brown F J  Damewood J R  Dantzman C L  Edwards P D  Jacobs R T  Mauger R C  Murphy M M  Palmer W  Pine K K  Rumsey W L  Garcia-Davenport L E  Shaw A  Steelman G B  Surian J M  Vacek E P
Institution:Department of Chemistry, AstraZeneca Pharmaceuticals, Wilmington, DE 19850-5437, USA. chris.veale@astrazeneca.com
Abstract:The cyclic peptide ANP 4-23 and the linear peptide analogue AP-811 have been shown to be selective ANP-CR antagonists. Via alanine scanning and truncation studies we sought to determine which residues in these molecules were important in their binding to the clearance receptor and the relationship between these two molecules. These studies show that several modifications to these compounds are possible which improve physical properties of these molecules while retaining high affinity for the ANP-CR.
Keywords:
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号